Evaluation of the Performance of a Robotic Flexible Ureteroscopy (ILY) in Laser Treatment of Nephrolithiasis
NCT ID: NCT03638336
Last Updated: 2020-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2018-10-31
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ILY Robotic System vs Manual Flexible Ureteroscopy for Kidney Stone Treatment
NCT06996587
Efficacy and Safety of Ureteroscopic Lithotripsy (Including Flexible Ureteroscopy) Without Indwelling Urinary Catheter
NCT06458101
Comparing Treatment of Urolithiasis Between Disposable and Reusable Ureteroscope
NCT03040466
Robotic Flexible Ureteroscopy Versus Standard Flexible Ureteroscopy for Renal Stones
NCT06660914
Flexible urétéroscopy Versus Extracorporeal Shockwave Lithotripsy in Renal Calculi
NCT01604304
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
flexible ureteroscopy
ILY robotic flexible ureteroscopy
fragmentation of nephrolithiasis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ILY robotic flexible ureteroscopy
fragmentation of nephrolithiasis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient must be a member or beneficiary of a health insurance plan
* The patient is at least 18 years old
* The patient has a single kidney stone in the calyx or the pelvis between 5 and 15mm something to do with a JJ probe
* Patient has an indication for in situ lithotripsy by supply ureteroscopy
Exclusion Criteria
* The patient is under safeguard of justice or state guardianship
* The subject refuses to sign the consent
* It is impossible to give the subject informed information
* The patient is pregnant or breastfeeding
* Patient treated with anticoagulants
* Documented untreated urinary infection within the previous 48 hours
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stéphane Droupy
Role: PRINCIPAL_INVESTIGATOR
CHU Nimes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Nimes
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IDIL/2016/SD-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.